| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.12.25 | SOLESENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| SOLESENCE Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | SOLESENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.11.25 | Solesence-Aktie bricht nach enttäuschenden Quartalszahlen und Umsatzrückgang ein | 23 | Investing.com Deutsch | ||
| 11.11.25 | Solesence GAAP EPS of -$0.02, revenue of $14.5M | 4 | Seeking Alpha | ||
| 11.11.25 | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | 885 | GlobeNewswire (Europe) | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| 10.11.25 | Solésence beruft Yoana Dvorzsak zur Vizepräsidentin für Innovation und Produktintegrität | 3 | Investing.com Deutsch | ||
| 10.11.25 | Solésence appoints Dvorzsak as VP of innovation and product integrity | 1 | Investing.com | ||
| 10.11.25 | Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity | 3 | GlobeNewswire (USA) | ||
| 06.11.25 | SOLESENCE, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 04.09.25 | Solesence ernennt neuen CEO und CFO und gibt Nachfolgeplan bekannt | 10 | Investing.com Deutsch | ||
| 29.08.25 | Solesence-Aktionäre bestätigen Direktoren und billigen Eigenkapitalplan | 22 | Investing.com Deutsch | ||
| 29.08.25 | SOLESENCE, INC. - 8-K, Current Report | 5 | SEC Filings | ||
| 31.07.25 | Solésence, Inc.: Solésence Reports Second Quarter 2025 Financial Results | 1.601 | GlobeNewswire (Europe) | ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced... ► Artikel lesen | |
| 07.04.25 | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | 1.753 | GlobeNewswire (Europe) | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
| 26.03.25 | Solésence, Inc.: Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results | 1.108 | GlobeNewswire (Europe) | Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB:... ► Artikel lesen | |
| 07.03.25 | Nanophase Technologies Rebrands as Solésence, Elevating the Future of Skin Health | 1.353 | GlobeNewswire (Europe) | ROMEOVILLE, Ill., March 07, 2025 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,400 | +0,65 % | EQS-DD: Formycon AG: Active Ownership Fund SICAV SIF SCS, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
14.01.2026 / 19:31... ► Artikel lesen | |
| GAUZY | 0,798 | 0,00 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| DOTZ NANO | 0,025 | +4,26 % | DOTZ NANO LIMITED: Becoming a substantial holder | ||
| ONTO INNOVATION | 179,00 | -0,56 % | Beyond The Numbers: 8 Analysts Discuss Onto Innovation Stock | ||
| KOPIN | 2,018 | +1,66 % | Kopin-Aktie legt zu: Rüstungsauftrag für Pilotenhelm-Displays erhalten | ||
| CANATU | 10,200 | 0,00 % | Canatu Oyj: Canatu and DENSO enter Joint Development Agreement to develop large-scale CNT chamber, supporting potential automotive applications such as full windshield heaters | Canatu Plc Press release 2 January 2026 at 09:00 am EET
Canatu and DENSO enter Joint Development Agreement to develop large-scale CNT chamber, supporting potential automotive applications such as full... ► Artikel lesen | |
| NANOLOGICA | 0,059 | 0,00 % | Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon | Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity... ► Artikel lesen | |
| RIBER | 5,200 | -0,57 % | Riber's full-year 2025 revenue falls by 2% to €40.3m, but second-half up 7% year-on-year | ||
| GOMSPACE | 2,100 | +0,24 % | GomSpace Group AB: GomSpace announces 2026 market guidance with strong profitable growth | GomSpace, a leading provider of small satellite solutions, today provides an update on its 2026 financial guidance.
The company is pleased to announce comprehensive market guidance for 2026, reflecting... ► Artikel lesen | |
| VEECO INSTRUMENTS | 25,000 | -2,34 % | Axcelis Technologies, Inc.: Axcelis Stockholders Approve Merger with Veeco | BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all... ► Artikel lesen | |
| ZENTEK | 0,555 | -3,48 % | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | |
| NANOVIRICIDES | 0,795 | -1,24 % | NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres | SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs... ► Artikel lesen | |
| OBDUCAT | 0,003 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 3,400 | -1,73 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 54,00 | 0,00 % | NVE Corp: Umsatzsprung um 23 % im dritten Quartal treibt Aktie an |